The prevalence of anxiety and internet addiction among adolescents during the coronavirus disease 2019.
Cybin Expands Clinical Team to Support CYB003 Phase 3 Program | Psychedelic Invest
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation